SecBot SecBot
PRESS-RELEASE ·Filed Jul 7, 2026

COSM

Cosmos Health Inc.
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago WireGlobeNewswire
Press release · Activist
Actionable Insight • Neutral

This is a routine buyback update with no financial disclosures. The continued repurchase at sub-$0.26 signals management's view of undervaluation, but the small scale (~0.15% of the $5M authorization per buyback) limits signal strength. Monitor next quarterly filing for revenue/cash flow context to assess whether buyback can be sustained.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
COSM ▲ +67.47% at T+60d
NEUTRAL call +67.47% · α vs SPY +65.48% · entry $0.2567 → $0.4299
Entry = T+0 close
Jul 7, 2026
via day close
T+1d
+2.80%
call +2.80% · α +3.11%
$0.2639
settled 4mo ago
T+5d
+19.63%
call +19.63% · α +19.08%
$0.3071
settled 4mo ago
T+20d
-8.45%
call -8.45% · α -9.79%
$0.2350
settled 3mo ago
T+60d
+67.47%
call +67.47% · α +65.48%
$0.4299
settled 27d ago

Price Chart

Loading chart...

Executive Summary

Cosmos Health repurchased an additional 230,000 shares (~$58,000) under its $5M buyback program, for a total of 3.87M shares (~$758,000). The program runs through Dec. 31, 2026, with CEO commentary about undervaluation — a routine capital allocation update with no material financial impact.

Key Financial Metrics

Deal Value
$58.4K

Key Facts

  • Repurchased 230,000 shares at ~$0.2539/share (~$58,397 total)
  • Total repurchases to date: 3,870,000 shares for ~$758,000
  • Program size remains up to $5 million (not fully utilized)
  • Program expires December 31, 2026
  • Buyback conducted via open market under Rules 10b5-1 and 10b-18

Financial Impact

~$58,000 incremental repurchase; total buyback is ~$758K out of $5M authorized (15% utilized)

dilutionshare count

Risk Factors

  • Low absolute dollar amount ($58K) relative to market cap ($17M) — buyback is symbolic, not transformative
  • No financial results or guidance provided — no fundamental catalyst

Market Snapshot

Exchange
Nasdaq
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3323580
33 reports for COSM
Performance horizon
50% Hit rate @ T+20 3 of 6 directional calls Went positive at some point 7 of 8 best @ T+60▲ +66.26%Jul 20, 2026
Filters
Rows
Reports for COSM — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
8-K
BULLISH ★ 6/10
$0.2530awaiting T+20—$0.2320 (−8.30%)
Oct 16, 2026
10d ago
SC 13G/A
NEUTRAL ★ 3/10
$0.3250awaiting T+20—$0.2320 (−28.62%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$0.3496awaiting T+20—$0.2320 (−33.64%)
Sep 3, 2026
7w ago
Press Release
BEARISH ★ 6/10
$0.2660 $0.4300▼ −61.65%▼ −62.77%$0.2320 (+12.78%)
Aug 19, 2026
9w ago
Press Release
BEARISH ★ 6/10
$0.1930awaiting T+20—$0.2320 (−20.21%)
Jul 20, 2026
14w ago
Press Release
BULLISH ★ 4/10
$0.2303 $0.2050▼ −10.99%▼ −15.11%$0.2320 (+0.74%)
Jul 17, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2348 $0.2179▼ −7.20%▼ −11.64%$0.2320 (−1.19%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2807 $0.2065▼ −26.43%▼ −30.05%$0.2320 (−17.35%)
Jul 15, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2785 $0.2071▼ −25.64%▼ −27.98%$0.2320 (−16.70%)
Jul 14, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.3071 $0.2198▼ −28.43%▼ −30.92%$0.2320 (−24.45%)
Showing 10 of 33

US Market Status

Market Closed — Opens in 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 7, 2026